Australia's most trusted
source of pharma news
Friday, 13 February 2026
Posted 13 February 2026 AM
She's been affectionately dubbed the 'First Lady of Australian Pharma' and after 51 years in industry, today is Jill Layton's last day before heading into retirement.
Layton is standing down from her position at Intas Pharmaceuticals as Head of Licensing and 3P Sales Asia Pacific.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.